SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001477932-19-005931
Filing Date
2019-10-17
Accepted
2019-10-17 17:23:28
Documents
79

Document Format Files

Seq Description Document Type Size
1 POS AM ipix_posam.htm POS AM 1069548
  Complete submission text file 0001477932-19-005931.txt   5901150

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ipix-20190630.xml EX-101.INS 885684
3 XBRL TAXONOMY EXTENSION SCHEMA ipix-20190630.xsd EX-101.SCH 94174
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20190630_def.xml EX-101.DEF 356778
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20190630_lab.xml EX-101.LAB 422785
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20190630_pre.xml EX-101.PRE 450199
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-220419 | Film No.: 191155994
SIC: 2834 Pharmaceutical Preparations